Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present AtriCure, Inc. (NASDAQ: ATRC).

Full DD Report for ATRC

You must become a subscriber to view this report.


Recent News from (NASDAQ: ATRC)

AtriCure's (ATRC) CEO Mike Carrel on Q1 2018 Results - Earnings Call Transcript
AtriCure, Inc. (ATRC) Q1 2018 Results Earnings Conference Call April 26, 2018 04:30 PM ET Executives Lynn Pieper - Westwicke Partners, LLC, MD Michael Carrel - President and Chief Executive Officer Andrew Wade - Senior Vice President and Chief Financial Officer Analysts Mat...
Source: SeekingAlpha
Date: April, 29 2018 04:34
AtriCure misses by $0.04, beats on revenue
AtriCure (NASDAQ: ATRC ): Q1 EPS of -$0.31 misses by $0.04 . More news on: AtriCure, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: April, 26 2018 16:35
AtriCure Reports First Quarter 2018 Financial Results
Worldwide revenue of $47.0 million – an increase of 13.9% year over year U.S. revenue of $38.4 million – an increase of 15.5% year over year International revenue of $8.6 million – an increase of 6.9% year over year AtriCure, Inc. ( Nasdaq: ATRC ), a l...
Source: Business Wire
Date: April, 26 2018 16:05
Institutional Top Ideas Series: DAFNA Capital Management
In the last entry of this recently rebooted series, we took a look at top ideas from Broadfin Capital (whose performance more than doubled that of the IBB during time frame we looked at). Going forward, I hope to continue delve into the portfolios of successful hedge funds predominantly ...
Source: SeekingAlpha
Date: April, 13 2018 01:03
Free Post Earnings Research Report: AtriCure's Quarterly Revenues Jumped 11.9%; Net Loss Narrowed
Stock Monitor: Akers Biosciences Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 09, 2018 / Active-Investors.com has just released a free earnings report on AtriCure, Inc. (NASDAQ: ATRC ). If you want access to this report all you need to do is sign up now by clicking the fo...
Source: ACCESSWIRE IA
Date: April, 09 2018 07:30
AtriCure to Announce First Quarter 2018 Financial Results
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its first quarter 2018 financial results on Thursday, April 26, 2018. AtriCure will host a conference call ...
Source: Business Wire
Date: April, 05 2018 08:00
AtriCure to Present at the Needham & Company's 17th Annual Healthcare Conference
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will present at the Needham & Company’s 17 th Annual Healthcare Conference at the Westin Grand Central ...
Source: Business Wire
Date: March, 15 2018 08:00
Free Research Report as ConforMIS Reported Better Than Expected Results
Stock Monitor: AtriCure Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 09, 2018 / Active-Investors.com has just released a free earnings report on ConforMIS, Inc. (NASDAQ: CFMS ). If you want access to this report all you need to do is sign up now by clicking the following ...
Source: ACCESSWIRE IA
Date: March, 09 2018 07:40
Report: Developing Opportunities within LCI Industries, Biglari, Graco, Federal Signal, AtriCure, and Perry Ellis International - Future Expectations, Projections Moving into 2018
NEW YORK, March 02, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of LCI Industries (NYSE:LCII), Biglari Holdings Inc. (NYSE:BH), Graco Inc. ...
Source: GlobeNewswire
Date: March, 02 2018 07:40
Your Daily Pharma Scoop: Clovis Q4 Results, Endocyte Update, Merrimack Doses First Patient In MM-121 Mid-Stage Study
Analysis of top Seeking Alpha coverage: Clovis Oncology Today we will once again look at Clovis Oncology ( CLVS ) after the company reported its Q4’17 results. We had covered CLVS last week in our scoop, noting that robust Rubraca (rucaparib) sales in Q4 could boost CLVS shares. Th...
Source: SeekingAlpha
Date: February, 28 2018 08:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1823.9024.0024.1223.66145,922
2018-05-1723.9024.0024.1223.66145,922
2017-02-0316.4616.4716.56616.26178,934
2017-02-0216.0816.3616.3715.975228,985
2017-02-0116.3616.1316.5416.06183,245

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-226,17017,50135.2551Short
2018-05-216,39439,58216.1538Cover
2018-05-187,01958,76911.9434Cover
2018-05-179,99350,93819.6180Cover
2018-05-1619,09833,79356.5147Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ATRC.


About AtriCure, Inc. (NASDAQ: ATRC)

Logo for AtriCure, Inc. (NASDAQ: ATRC)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $831,850,763 - 05/11/2018
  • Issue and Outstanding: 35,040,049 - 04/24/2018

 


Recent Filings from (NASDAQ: ATRC)

Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 14 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 26 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 10 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 02 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 28 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 20 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 16 2018

 

 


Daily Technical Chart for (NASDAQ: ATRC)

Daily Technical Chart for (NASDAQ: ATRC)


Stay tuned for daily updates and more on (NASDAQ: ATRC)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ATRC)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ATRC is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of ATRC and does not buy, sell, or trade any shares of ATRC. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/